Studies on the suitability of alpha-hybrid interferon application in cattle.
Twelve cattle with body wts ranging from 100 to 250 kg were treated using various doses and routes for four days with an E. coli derived alpha-hybrid interferon. The lowest parenteral doses (10(4) units per kg body wt) and the orally administered interferon did not lead to any disturbances, whereas the higher dosages led to marked changes in body temperature, pulse and respiration rates. Animals with the highest dose (10(8) units per kg body wt) became extremely distressed. The blood picture showed distinct changes, with very low leukocyte counts during treatment, which took weeks to recover. It is suggested that the dosages that did not lead to clinical symptoms are best suited for prophylactic or therapeutic purposes.
BFAV, Tübingen, Germany.
O C
OC
Straub
D000284:Administration, Oral; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000302:isolation & purification / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002417:Cattle / Q000097:blood / Q000502:physiology*; D004926:Escherichia coli / Q000737:chemistry; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D007275:Injections, Intravenous; D016898:Interferon-alpha / Q000008:administration & dosage / Q000302:isolation & purification / Q000494:pharmacology*; D007958:Leukocyte Count / Q000187:drug effects / Q000662:veterinary; D012119:Respiration / Q000187:drug effects
D000998:Antiviral Agents; D016898:Interferon-alpha